MV-4-11 In Vitro High Content Screening (HCS) Assay

CAT#: ITS-1122-YF4401
Target Cell Organism: Human
Target Cell Alternative Name: MV(4;11)
Target Cell Name: MV-4-11
Assay Type: High-throughput Screening, High Content Screening and Reporter Gene Assays
Assay Overview
This assay is to provide MV-4-11-based In Vitro High Content Screening (HCS) Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
MV-4-11
Target Cell Organism
Human
Target Cell Background
A model of human AML (acute myeloid leukemia) Acute myeloid leukemia (AML) is a malignant disorder of the progenitor cells in myeloid hematopoiesis and represents a genetically heterogeneous cancer.
Target Cell Alternative Name
MV(4;11)
Related Diseases
Acute Myeloid Leukemia; AML
Research Area
Oncology
Assay Name
In Vitro High Content Screening (HCS) Assay
Short Description
MV-4-11-cell based In Vitro High Content Screening (HCS) Assay
Assay Description
HCS is one of the latest techniques used in cancer drug discovery programs. Unlike traditional HTS platforms, HCS provides more visual information about the experiment being conducted. HCS is a very powerful tool for multivariate and quantitative data analysis. Cellbased HCS systems have also gained much attention in biological research and cancer drug discovery programs.
Assay Type
High-throughput Screening, High Content Screening and Reporter Gene Assays
For Research Use Only | Not For Clinical Use
Online Inquiry